OpenLB
Open Library of Bioscience
Advanced Search
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
01, 2025;65 (1): 39-46.

Management of monochorionic diamniotic twin gestation affected by Type-II selective fetal growth restriction: cost-effectiveness analysis.

J C Morgan, J Rios, T Kahl, M Prasad, A Rausch, R Longman, S Mehra, A Shaaban, A Premkumar
Author Information
  1. J C Morgan: Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA. ORCID
  2. J Rios: Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  3. T Kahl: Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  4. M Prasad: Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  5. A Rausch: Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA. ORCID
  6. R Longman: Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
  7. S Mehra: Center for Fetal Care, Advocate Children's Hospital, Park Ridge, IL, USA.
  8. A Shaaban: Chicago Institute for Fetal Health, Ann and Robert H. Lurie's Children's Hospital, Chicago, IL, USA.
  9. A Premkumar: Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.
PMID: 39602652 DOI: 10.1002/uog.29135

Abstract

OBJECTIVE: Monochorionic twin gestations affected by Type-II selective fetal growth restriction (sFGR) are at increased risk of intrauterine fetal demise, extreme preterm birth, severe neurodevelopmental impairment (NDI) and neonatal death of one or both twins. In the absence of a consensus on the optimal management strategy, we chose to evaluate which strategy was cost-effective in the setting of Type-II sFGR.
METHODS: A decision-analytic model was used to compare expectant management (EM), bipolar cord occlusion (BCO), radiofrequency ablation (RFA) and fetoscopic laser photocoagulation (FLP) for a hypothetical cohort of 10 000 people with a monochorionic diamniotic twin pregnancy affected by Type-II sFGR. Probabilities and utilities were derived from the literature. Costs were derived from the Healthcare Cost and Utilization Project and adjusted to 2023 USD. The analytic horizon, taken from the perspective of the pregnant patient, extended throughout the life of the child or children. An incremental cost-effectiveness ratio of 50 000 USD per quality-adjusted life year defined the willingness-to-pay threshold. One-way and probabilistic sensitivity analysis was also performed.
RESULTS: For base-case estimates, RFA was the most cost-effective strategy compared with all of the other interventions included, with an incremental cost-effectiveness ratio of 14 243 USD per quality-adjusted life year. One-way sensitivity analysis demonstrated that the utilities assigned to fetal demise and severe NDI, as well as the costs of preterm birth before 32 weeks, most strongly impacted the model outcomes. On probabilistic sensitivity analysis, RFA was the most cost-effective strategy in 78% of runs, followed by BCO at 20%, EM at 2% and FLP in 0% of runs. When compared with EM, RFA led to 58 fewer births before 28 weeks' gestation, 273 fewer cases of severe NDI and 22 more deliveries after 32 weeks. When compared with FLP, RFA resulted in 259 fewer cases of severe NDI and 3177 more births after 32 weeks. When compared with BCO, RFA resulted in 1786 more neurologically intact neonates and 34 fewer cases of severe NDI.
CONCLUSIONS: On base-case analysis, RFA was found to be the most cost-effective strategy in the management of monochorionic diamniotic twin pregnancies affected by Type-II sFGR. However, these findings were not robust on sensitivity analysis, indicating the potential benefit of BCO and EM. In the absence of large clinical trials, these data should not be taken to guide management. Future studies should evaluate management strategies for Type-II sFGR related to long-term neonatal outcomes, inclusive of quality-of-life indicators, in a prospective multicenter cohort. © 2024 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Keywords

fetal growth restriction intervention laser monochorionic diamniotic multifetal photocoagulation radiofrequency

References

Ultrasound Obstet Gynecol. 2019 Jan;53(1):36-46 [PMID: 30207011]
Early Hum Dev. 2011 Sep;87(9):601-6 [PMID: 21831543]
Fetal Diagn Ther. 2023;50(1):47-53 [PMID: 36623493]
Pediatrics. 2009 Jul;124(1):251-7 [PMID: 19564307]
Natl Vital Stat Rep. 2023 Jan;72(1):1-53 [PMID: 36723449]
Obstet Gynecol. 2018 Mar;131(3):581-590 [PMID: 29420402]
J Pediatr. 2019 Jan;204:118-125.e14 [PMID: 30297293]
Acta Obstet Gynecol Scand. 2012 Oct;91(10):1201-5 [PMID: 22708557]
Natl Vital Stat Rep. 2022 Aug;71(1):1-64 [PMID: 35947823]
N Engl J Med. 2005 Jan 6;352(1):9-19 [PMID: 15635108]
Fetal Diagn Ther. 2009;26(3):157-61 [PMID: 19864880]
BJOG. 2005 Oct;112(10):1344-8 [PMID: 16167936]
N Engl J Med. 2014 Aug 28;371(9):796-7 [PMID: 25162885]
Semin Perinatol. 2021 Apr;45(3):151390 [PMID: 33541716]
J Matern Fetal Neonatal Med. 2022 Mar;35(6):1184-1191 [PMID: 32233709]
Prenat Diagn. 2022 Aug;42(9):1094-1110 [PMID: 35808908]
Am J Obstet Gynecol MFM. 2022 Sep;4(5):100676 [PMID: 35714861]
Aust N Z J Obstet Gynaecol. 2013 Apr;53(2):114-8 [PMID: 23577786]
Birth. 1999 Sep;26(3):178-83 [PMID: 10655818]
Ultrasound Obstet Gynecol. 2017 Nov;50(5):559-568 [PMID: 27859836]
Ultrasound Obstet Gynecol. 2017 May;49(5):607-611 [PMID: 27153404]
Ultrasound Obstet Gynecol. 2023 Sep;62(3):369-373 [PMID: 36704956]
Ultrasound Obstet Gynecol. 2007 Jul;30(1):28-34 [PMID: 17542039]
Ultrasound Obstet Gynecol. 2012 Apr;39(4):407-13 [PMID: 22173905]
Am J Obstet Gynecol. 2021 May;224(5):528.e1-528.e12 [PMID: 33248135]
BJOG. 2015 Oct;122(11):1517-24 [PMID: 26147116]
Semin Fetal Neonatal Med. 2010 Dec;15(6):342-8 [PMID: 20675206]
J Pediatr. 2009 Jul;155(1):21-5, 25.e1-5 [PMID: 19394030]
Ultrasound Obstet Gynecol. 2008 Jun;31(6):669-75 [PMID: 18504780]
Med Care. 2000 Jun;38(6):583-637 [PMID: 10843310]
BJOG. 2024 Feb 20;: [PMID: 38379063]
Fetal Diagn Ther. 2016;39(3):186-91 [PMID: 26344150]
BMC Pregnancy Childbirth. 2021 Mar 6;21(1):189 [PMID: 33676436]
BJOG. 2021 Jan;128(2):401-409 [PMID: 32416618]
J Matern Fetal Neonatal Med. 2021 May;34(10):1513-1521 [PMID: 31309857]
Am J Public Health. 1996 Jun;86(6):809-14 [PMID: 8659654]
Acta Paediatr. 2012 Dec;101(12):1200-5 [PMID: 22946904]
Ultrasound Obstet Gynecol. 2013 Jun;41(6):653-8 [PMID: 23335029]
J Clin Med. 2019 Jun 28;8(7): [PMID: 31261823]
J Obstet Gynaecol Can. 2023 Aug;45(8):587-606.e8 [PMID: 37541734]
BJOG. 2003 Feb;110(2):121-7 [PMID: 12618154]
Chin Med J (Engl). 2010 Mar 5;123(5):549-54 [PMID: 20367979]
Am J Obstet Gynecol. 2010 Mar;202(3):253.e1-7 [PMID: 20207244]
Ultrasound Obstet Gynecol. 2010 Jul;36(1):37-41 [PMID: 20104533]
Am J Obstet Gynecol. 2003 Apr;188(4):876-80 [PMID: 12712079]
Ultrasound Obstet Gynecol. 2020 May;55(5):652-660 [PMID: 31273879]
J Gynecol Obstet Hum Reprod. 2017 Dec;46(10):731-736 [PMID: 28964964]
Clinics (Sao Paulo). 2018;73:e210 [PMID: 29723347]
Am J Obstet Gynecol. 2020 Nov;223(5):B16-B20 [PMID: 32861686]
J Perinatol. 2009 Aug;29(8):543-7 [PMID: 19339984]

MeSH Term

Humans
Female
Pregnancy
Cost-Benefit Analysis
Pregnancy, Twin
Fetal Growth Retardation
Infant, Newborn
Radiofrequency Ablation
Fetoscopy
Quality-Adjusted Life Years
Laser Coagulation
Twins, Monozygotic
Decision Support Techniques
Watchful Waiting
Premature Birth
Cost-Effectiveness Analysis
Journal Article Research Support, Non-U.S. Gov't

Word Cloud

Similar Articles

Cited By